Novel anticoagulants part II. Joe Basha, CCP explores more about novel anticoagulants and the unique challenges associated with them in the cardiac surgery patient.
Joseph has been a practicing clinical perfusionist for 40 years. Joseph is the CEO of Houston Extracorporeal Technologies and is the program director of The New Orleans Conference